These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14965491)

  • 21. [New thrombocyte aggregation inhibitor in therapy of unstable angina].
    Hamm C
    Z Kardiol; 2000 Nov; 89(11):1053-6. PubMed ID: 11149273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
    Ferguson JJ; Antman EM; Bates ER; Cohen M; Every NR; Harrington RA; Pepine CJ; Theroux P;
    Am Heart J; 2003 Oct; 146(4):628-34. PubMed ID: 14564315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-world safety and efficacy of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention.
    Casterella PJ; Revenaugh JR; Burke JL; Pearson RR; Bair TL; May HT; Horne B; Anderson JL; Muhlestein JB
    J Invasive Cardiol; 2008 Mar; 20(3):94-8. PubMed ID: 18316822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists.
    Ilveskero S; Lassila R
    Thromb Res; 2006; 117(3):291-7. PubMed ID: 15878612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uneventful use of tirofiban as an adjunct to coronary stenting in a patient with a history of abciximab-associated thrombocytopenia 10 months earlier.
    Desai M; Lucore CL
    J Invasive Cardiol; 2000 Feb; 12(2):109-12. PubMed ID: 10731275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s).
    Rikken SAOF; van 't Hof AWJ; Ten Berg JM; Kereiakes DJ; Coller BS
    J Am Heart Assoc; 2023 Dec; 12(24):e031855. PubMed ID: 38063187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical use of glycoprotein IIb/IIIa inhibitors].
    Simonetti I; Gallopin M; Gensini GF
    Ann Ital Med Int; 1998; 13(3):163-8. PubMed ID: 9859573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An audit of the use and complications of glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention against national UK standards.
    Sheikh A; Baig K
    Cardiovasc Revasc Med; 2006; 7(4):237-9. PubMed ID: 17174871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of tirofiban, a nonpeptide glycoprotein IIb/IIIa receptor antagonist: comparison with the monoclonal antibody abciximab.
    Kondo K; Umemura K
    Clin Pharmacokinet; 2002; 41(3):187-95. PubMed ID: 11929319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute profound thrombocytopenia without bleeding complications after re-administration of abciximab.
    Nguyen N; Salib H; Mascarenhas DA
    J Invasive Cardiol; 2001 Jan; 13(1):56-8. PubMed ID: 11146690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alveolar hemorrhage: an underdiagnosed complication of treatment with glycoprotein IIb/IIIa inhibitors.
    Iskandar SB; Kasasbeh ES; Mechleb BK; Garcia I; Jackson A; Fahrig S; Albalbissi K; Henry PD
    J Interv Cardiol; 2006 Aug; 19(4):356-63. PubMed ID: 16881986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombocytopenia and glycoprotein IIb-IIIa receptor antagonists.
    Stiegler HM; Fischer Y; Steiner S
    Lancet; 1999 Apr; 353(9159):1185. PubMed ID: 10210005
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets.
    Jeske WP; Walenga JM; Szatkowski E; Ero M; Herbert JM; Haas S; Bakhos M
    Thromb Res; 1997 Nov; 88(3):271-81. PubMed ID: 9526947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: a nemesis of platelet glycoprotein IIb/IIIa inhibitors.
    Ali A; Patil S; Grady KJ; Schreiber TL
    Catheter Cardiovasc Interv; 2000 Feb; 49(2):181-4. PubMed ID: 10642769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies.
    Untch B; Ahmad S; Messmore HL; Schultz CL; Ma Q; Hoppensteadt DA; Walenga JM; Fareed J
    Thromb Res; 2002 Apr; 106(2):149-56. PubMed ID: 12182915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban.
    Marciniak SJ; Jordan RE; Mascelli MA
    Thromb Haemost; 2001 Mar; 85(3):539-43. PubMed ID: 11307828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia.
    Mak KH; Kottke-Marchant K; Brooks LM; Topol EJ
    Thromb Haemost; 1998 Dec; 80(6):989-93. PubMed ID: 9869172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of bleeding complications associated with glycoprotein IIb/IIIa inhibitors.
    Brouse SD; Wiesehan VG
    Ann Pharmacother; 2004 Nov; 38(11):1783-8. PubMed ID: 15383640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.
    Tcheng JE
    Am Heart J; 2000 Feb; 139(2 Pt 2):S38-45. PubMed ID: 10650315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: IIb or Not IIb, what is the question?
    Young JJ; Kereiakes DJ
    J Invasive Cardiol; 2002 Jul; 14(7):404-10. PubMed ID: 12082194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.